findmyKOL

Robert Carney, MD

Enriched profile

Professor Emeritus of Psychiatry · Washington University in St. Louis

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Tyler, TX · South Central · United StatesSpecialtyCardiovascular DiseaseFocusCardiac Health and Mental Health+4
Active KOLfindmyKOL type: NationalLatest publication2020Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Robert Carney is Professor Emeritus of Psychiatry at Washington University in St. Louis. OpenAlex indexes 300 publications with 28,694 citations (h-index 78); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 13 Oct 2026

Robert M. Carney, MD, is Professor Emeritus of Psychiatry at Washington University in St. Louis (Department of Psychiatry, WashU Medicine). The public record shows 300 publications with 28,694 citations (h-index 78), centered on Cardiac Health and Mental Health, Heart Rate Variability and Autonomic Control, Heart Failure Treatment and Management. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 35 companies.

  • Most recent indexed publication: 2020 · CNS drugs
  • Top research focus: Cardiac Health and Mental Health
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 35 companies

Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Depression (MDD)4 trialsCoronary Artery Disease / ACS3 trialsCardiovascular Diseases1 trialMyocardial Infarction1 trialVascular Diseases1 trialAngina, Unstable1 trialInfarction1 trialAcute Coronary Syndrome1 trialHeart Failure

Research focus

OpenAlex concept fingerprint
Cardiac Health and Mental HealthHeart Rate Variability and Autonomic ControlHeart Failure Treatment and ManagementHeart rate and cardiovascular healthMental Health Treatment and Access

Drugs & molecules

across trials, industry payments and publications
Verquvogeneric · VericiguatClinical trials—Industry payments73Publications—Leqviogeneric · InclisiranClinical trials—Industry payments46Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments45Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments41Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments24Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments19Publications—Repathageneric · EvolocumabClinical trials—Industry payments17Publications—Xareltogeneric · RivaroxabanClinical trials—Industry payments13Publications—Rybelsusgeneric · SemaglutideClinical trials—Industry payments11Publications—Camzyosgeneric · MavacamtenClinical trials—Industry payments10Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments9Publications—Onpattrogeneric · PatisiranClinical trials—Industry payments9Publications—

Works with

trial sponsors and companies reporting payments
Novartis Pharmaceuticals CorporationClinical trials—Industry payments85Merck Sharp & Dohme LLCClinical trials—Industry payments41E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments32Medtronic, Inc.Clinical trials—Industry payments28Esperion Therapeutics, Inc.Clinical trials—Industry payments24AstraZeneca Pharmaceuticals LPClinical trials—Industry payments23Pfizer Inc.Clinical trials—Industry payments22Amgen Inc.Clinical trials—Industry payments17ShockWave Medical, IncClinical trials—Industry payments16Janssen Pharmaceuticals, IncClinical trials—Industry payments13ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments12Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments9Sanofi-Aventis U.S. LLCClinical trials—Industry payments9Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments8Novo Nordisk IncClinical trials—Industry payments6Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments5Merck Sharp & Dohme CorporationClinical trials—Industry payments5Boston Scientific CorporationClinical trials—Industry payments4CVRx, Inc.Clinical trials—Industry payments3Lexicon Pharmaceuticals, Inc.Clinical trials—Industry payments3Washington University School of MedicineClinical trials3Industry payments—Amarin Pharma Inc.Clinical trials—Industry payments2Philips Electronics North America CorporationClinical trials—Industry payments2Surmodics, Inc.Clinical trials—Industry payments2Abbott LaboratoriesClinical trials—Industry payments1AltaThera Pharmaceuticals LLCClinical trials—Industry payments1Biotronik Inc.Clinical trials—Industry payments1Columbia UniversityClinical trials1Industry payments—iRhythm Technologies, Inc.Clinical trials—Industry payments1Kiniksa Pharmaceuticals International, plcClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
300publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

28,694citations

Total citations across indexed works.

78h-index

Hirsch index (OpenAlex). i10-index 197.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
35companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Oct 2026

35 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.6%
    Beta blocker16.3%
    Carvedilol41%Metoprolol Tartrate35%Metoprolol Succinate15%Sotalol5%Atenolol2%Propranolol Hcl1%Bisoprolol Fumarate1%
    Part D<11 patients
    Cholesterol absorption inhibitor9.2%
    Ezetimibe100%
    Part D≥297 patients

    + 21 more classes in this area

  • Blood & clotting

    13.2%
    Factor Xa inhibitor6.8%
    Eliquis84%Xarelto17%
    Part D≥138 patients
    P2Y12 inhibitor5.2%
    Clopidogrel90%Prasugrel Hcl10%
    Part D≥146 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    8.5%
    Potassium supplement6.1%
    Potassium Chloride100%
    Part D≥214 patients
    SGLT2 inhibitor1.3%
    Jardiance77%Farxiga23%
    Part D≥35 patients

    + 1 more class in this area

All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)11% facility · 89% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 13 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 13 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Kenneth E. Freedland197Michael W. Rich54Brian C. Steinmeyer41Allan S. Jaffe38Phyllis K. Stein33James A. Blumenthal33Judith A. Skala25David S. Sheps25Patrick J. Lustman20Frank Doyle19Susan M. Czajkowski17Eugene H. Rubin17Matthew M. Burg16Peter Kaufmann14Junichiro Hayano13Lana L. Watkins12Peter de Jonge12Lisa Berkman12Diane Catellier11Peter P. Domitrovich11David Byrne10Pim Cuijpers10Nancy Frasure‐Smith10Karina W. Davidson10Fiona Boland10Alexandra L. Dima10Stephen P. Duntley10David Hevey9Gregory E. Miller9Suzanne Guérin9Bishember Kathuria9Susan Brannick8Emma Wallace8Annelieke M. Roest8Barry A. Hong8Ray E. Clouse8Jeffrey F. Scherrer7Víctor G. Dávila‐Román7James M. Raczynski7Michael A. Babyak7

Online presence

Updated 13 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/profile/Robert-Carney-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    medicine.washu.edu/news/tag/robert-m-carney

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
  • ResearchGate

    ResearchGate profile listing him as Professor Emeritus, Department of Psychiatry, Washington University in St. Louis

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • Doximity

    Doximity profile: Dr. Robert Carney, MD, St. Louis, MO (note: Doximity credential listed as MD appears to be a data-quality artifact/possible conflation, since all primary sources list him as PhD, not MD)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Ph.D.

    Washington University in St. Louis

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • B.A.

    University of Missouri Columbia

    1969
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatry.wustl.edu ↗

Editorial & leadership roles

journal and society appointments
  • Professor Emeritus of Psychiatry

    Washington University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • Faculty member

    Institute of Clinical and Translational Sciences, Washington University in St. Louis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →icts.wustl.edu ↗

Awards & honors

honors on the public record
  • Wayne Katon Research Award

    Academy of Psychosomatic Medicine

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • Fellow

    Academy of Cognitive Therapy

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • Fellow

    Society of Behavioral Medicine

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • Fellow

    Academy of Behavioral Medicine Research

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
  • Visiting Scholar

    American Psychosomatic Society

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.